Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 14, 2022
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. ...
read more
Wednesday, August 21, 2024
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has acquired ZenBio Inc., a provider of advanced cell products and services. Together, BioIVT and ZenBio will offer an expanded portfolio of ...
read more
Wednesday, September 10, 2025
BioIVT announced the company is expanding with new office space and a laboratory facility in Woodbury, New York.
read more
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
read more
Biokin Pharmaceutical and Cryoport announced Cryoport's temperature-controlled solutions will support Biokin Pharma's pending Phase I and II clinical trials in immuno-oncology in both the U.S. and China.
read more
BioLegend and the NYGC have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq technology for use in the research field.
read more
Wednesday, January 10, 2018
BioLife Solutions announced preliminary Q4 and full year 2017 revenue and provided additional operational updates and financial guidance for 2018.
read more
BioLife Solutions has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a developer of advanced cold chain management tools for cell and gene therapies.
read more
Wednesday, August 10, 2016
BioLife Solutions, Inc., a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers, ...
read more
Wednesday, November 29, 2017
BioLife Solutions has executed a new confidential agreement to supply its proprietary CryoStor cell freeze media to a T cell therapy customer.
read more
Wednesday, February 14, 2018
BioLife Solutions has executed an OEM agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media under private label to MilliporeSigma.
read more
Wednesday, December 13, 2017
BioLife Solutions has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.
read more
BioLife Solutions announced a $1 million equity investment in SAVSU Technologies, a designer and manufacturer of high-performance cloud-connected storage and transport containers optimized for the cell and gene therapy supply chain.
read more
Tuesday, October 31, 2017
BioLife Solutions and SAVSU announced both companies are providing their respective enhanced cold chain technologies for use in eight active and pending clinical trials.
read more
Genentech has commenced a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ).
read more